Aura A. J. van Esch

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Marieke J. H. Coenen, Dirk J. de Jong, Corine J. van Marrewijk et al. · Gastroenterology · 2015 · 197 citations · Full text

Medicine, Hematology, Pharmacology +14

Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study

Lisa Smits, Lauranne Derikx, Dirk J. de Jong et al. · Journal of Crohn s and Colitis · 2016 · 140 citations

Pharmacy, Immunology, Pharmacotherapy +15

Long-Term Clinical Outcomes After Switching from Remicade® to Biosimilar CT-P13 in Inflammatory Bowel Disease

Lisa Smits, Anna Grelack, Lauranne Derikx et al. · Digestive Diseases and Sciences · 2017 · 68 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +10

Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study

Lisa Smits, Aura A. J. van Esch, Lauranne Derikx et al. · Inflammatory Bowel Diseases · 2018 · 32 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Dutch Gastrointestinal Endoscopy Audit: automated extraction of colonoscopy data for quality assessment and improvement

Michael P.M. de Neree tot Babberich, M. Ledeboer, Monique E. van Leerdam et al. · Gastrointestinal Endoscopy · 2020 · 28 citations

Medicine, Clinical Sciences, Health Informatics +6